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Abstract: Our objective was to examine the relationship between estimated maternal exposure
to pesticides in public drinking water and the risk of congenital heart defects (CHD). We used
mixed-effects logistic regression to analyze data from 18,291 nonsyndromic cases with heart defects
from the Texas Birth Defects Registry and 4414 randomly-selected controls delivered in Texas from
1999 through 2005. Water district-level pesticide exposure was estimated by linking each maternal
residential address to the corresponding public water supply district’s measured atrazine levels.
We repeated analyses among independent subjects from the National Birth Defects Prevention
Study (NBDPS) (1620 nonsyndromic cases with heart defects and 1335 controls delivered from 1999
through 2005). No positive associations were observed between high versus low atrazine level and
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eight CHD subtypes or all included heart defects combined. These findings should be interpreted
with caution, in light of potential misclassification and relatively large proportions of subjects with
missing atrazine data. Thus, more consistent and complete monitoring and reporting of drinking
water contaminants will aid in better understanding the relationships between pesticide water
contaminants and birth defects.
Keywords: pesticide; congenital heart defect; public drinking water; Texas; birth defects
1. Introduction
Congenital heart defects (CHDs) are among the most common congenital malformations,
occurring in nearly 1% of live births [1]. CHDs account for approximately one-third of birth defects
and are a leading cause of infant mortality due to birth defects [2,3]. The etiology of CHDs is poorly
understood in the majority of nonsyndromic CHD cases (i.e., those that do not occur due to a recognized
genetic syndrome). The prevalence of these defects varies by subtype of CHD [4], geography [5], and
season of conception [6,7], which may suggest the involvement of environmental risk factors, such as
pesticides, that also vary by geography and season.
In animal studies, some pesticides (e.g., organo-phosphorous pesticides, glyphosate) have been
shown to have reproductive toxicity and teratogenic effects [8,9]. Observational studies in humans have
reported associations between CHDs in offspring and parental occupational pesticide exposure [10],
as well as residential proximity to agricultural areas where pesticides are applied [11–13]. Similar
associations have been observed with other birth defects [14–17].
Water contamination may be an important source of human pesticide exposure, and higher versus
lower maternal residential tap water consumption has been associated with CHDs in offspring [18].
The pesticide atrazine is of particular interest because it is one of the most widely applied agricultural
pesticides in the U.S. [19], is present at substantial levels in ground water supplies (e.g., ≥0.003 mg/L,
the U.S. Environmental Protection Agency (EPA) drinking water standard) [20,21], and is suspected to
have adverse reproductive effects [21]. However, to our knowledge, no published study has evaluated
atrazine or other pesticides in drinking water and CHD risk. In fact, we are aware of only three studies
that have assessed associations between pesticides in water and any birth defect [22–24]. To address
this gap, we examined the association between estimated maternal atrazine exposure via residential
water district data from the EPA and risk for CHDs in offspring, using two independent data sources,
the Texas Birth Defects Registry, and the National Birth Defects Prevention Study.
2. Materials and Methods
2.1. Texas Birth Defects Registry
The Texas Birth Defects Registry is an active, ongoing, population-based registry of birth defects
that is maintained by the Texas Department of State Health Services Birth Defects Epidemiology
and Surveillance Branch. Information on the Registry’s data collection methods has been described
in a previous paper [25]. Briefly, trained Registry staff review records at birthing centers, midwife
facilities, and hospitals statewide to identify cases with birth defects (live births, still births, or induced
pregnancy terminations). Cases reported in the Registry must have a diagnosis of a structural birth
defect or chromosome abnormality within one year of delivery to a mother residing in Texas at the
time of birth. Registry staff abstract medical charts for each case, review case diagnoses, and assign a
modified British Pediatric Association (BPA) code for each diagnosis [26]. Registry data are also linked
to vital records (birth and fetal death certificates) from the Vital Statistics Unit of the Texas Department
of State Health Services. These data were obtained and the analyses were conducted with approval
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from the Institutional Review Boards of the University of Texas Health Science Center at Houston and
the Texas Department of State Health Services.
In this study, cases were defined as subjects with any structural CHD (BPA codes: 745.000–745.490,
745.510–745.900, 746.000–746.995, 747.100–747.320, 747.330–747.490) delivered from 1 January 1999
through 31 December 2008. We excluded births that only had a patent ductus arteriosus, patent
foramen ovale, anomaly of umbilical artery, peripheral vascular system defect, pulmonary artery
branch stenosis, or circulatory system anomaly. We further limited our analyses to those cases with
documented diagnoses after delivery and no chromosome abnormality/syndrome. A total of 10,000
controls were randomly selected among all live born infants without known major malformations
(i.e., not present in the Registry) delivered in Texas during the same study period. Subjects without
a geocoded maternal address at delivery were excluded. Data on demographic and reproductive
characteristics (i.e., potential confounders) were obtained from vital records. For the main analyses,
cases and controls were restricted to subjects who were delivered from 1 January 1999 through
31 December 2005 (i.e., years with atrazine measurements, described below).
2.2. Water District Assignment
Our overall exposure assessment was based on linking each residential maternal address to the
corresponding water supply district and estimating atrazine exposure based on measured levels for
the district, as described below. The maternal address at delivery, as listed on vital records, was used
as a proxy for address at conception. Only one address was reported for each mother. We obtained a
map of geocoded boundaries for all public water systems in Texas from the Texas Water Development
Board [27]. Each maternal address was converted to geocoded coordinates and these coordinates were
overlaid with the water system map to identify the corresponding water district for each address.
2.3. Exposure Assessment
We obtained data on atrazine measurements from each water district’s routine monitoring
during 1998–2005 from the Environmental Protection Agency (EPA) (https://www.epa.gov/
dwsixyearreview/six-year-review-2-contaminant-occurrence-data-1998-2005) [28]. The EPA requires
quarterly monitoring except under certain conditions when it allows reduced monitoring. If a water
system meets certain criteria, EPA grants waivers from the regular monitoring (40 CFR Part 141.24) [29].
If the measurements are consistently below the detectable assay limit, EPA guidelines allow for less
frequent testing [30]. Measurements at or below the limit of detection for the assay were coded as
0 µg/L for our main analysis, based on an approach proposed by Rinsky et al. [30]. Sensitivity analyses
were also conducted, coding such measurements as the minimum detectable value for the assay instead.
In our study, each subject was linked to atrazine measurements by matching residential addresses
and public water districts. Because many districts did not have atrazine measurements at frequent
and regular intervals (and in some instances measurements were not available during the period of
the pregnancy, see Results), we used the mean of atrazine levels during the entire monitoring period
(1999–2005) for each subject’s district. Based on the distributions in controls, mean atrazine values were
categorized as “low” (<the 85th percentile) or “high” (≥the 85th percentile). For secondary analyses,
the median atrazine levels were also categorized, using the same percentiles.
2.4. Statistical Analysis
Demographic characteristics of cases and controls in Texas who had atrazine information were
compared using the 2-sided χ2 test. Because a large proportion of both cases and controls were missing
atrazine levels (see Results), we also compared characteristics of those with and without atrazine
data among all potential controls and compared the association between missing atrazine data and
any CHD, using a 2-sided χ2 test. Odds ratios (ORs) and 95% confidence intervals (CIs) were also
estimated for these comparisons.
Int. J. Environ. Res. Public Health 2017, 14, 889 4 of 17
We evaluated the association between high mean atrazine level and each of the eight CHD
subtypes (e.g., conotruncal heart defects), as well as the combined group of any CHD (i.e., to assess
the impact of missing atrazine measurements within population subgroups, see below and Results).
To account for the correlation (i.e., clustering) between atrazine exposure and geographic location
resulting from the use of a water district-level exposure assessment, mixed-effects (random-effects)
models for logistic regression were used to investigate the association between maternal atrazine
exposure and the risk of CHDs in offspring. Thus, we modeled subjects’ public water district as
a random effect. We estimated crude and adjusted ORs and 95% CIs, using the lowest atrazine
exposure category as the reference group. All models were adjusted for literature-based, a priori
potential confounders that could be associated with atrazine and congenital heart defects: delivery year,
maternal age at delivery (<20, 20–24, 25–29, 30–34, 35–39, and≥40 years), race/ethnicity (non-Hispanic
White, non-Hispanic Black, Hispanic, and other), education (less than high school, high school, and
greater than high school), birth place (U.S. or outside of the U.S.), smoking (yes or no), and previous
live birth (yes or no). In a secondary model, we adjusted for the population size served by the
subject’s water district (<5000, 5000–200,000, and >200,000) and urban/rural status (metropolitan,
non-metropolitan but urban, and less urbanized) because of large differences in the proportion of
subjects missing atrazine data between categories of these variables. For all of our analyses, we did
not conduct comparisons for CHD subgroups in which fewer than 50 water districts were represented
among cases, due to concerns regarding model validity and convergence in mixed models with
group-level sparseness [31,32].
To limit the potential for selection bias related to the exclusion of subjects without atrazine
exposure data, we repeated our analysis of any CHD among subjects who lived in districts that served
>200,000 people, because these larger districts had few subjects missing atrazine exposure. (Analyses
of specific CHDs were not performed under this secondary model due to small numbers in some
groups.) This analysis was repeated using the median atrazine level instead of the mean. To assess
the extent of selection bias related to missing atrazine, we repeated the main analysis of any CHD
with a 3-level exposure variable (i.e., low/high/missing). Additionally, we performed two sensitivity
analyses for the analysis of any CHD: (1) excluding subjects from region 11 (south Texas), where
over-ascertainment of CHDs is suspected [5,33], and (2) expanding to include subjects delivered from
1999–2008 (i.e., to improve power and analyze more recent years). All analyses were performed using
SAS version 9.3 (SAS Institute, Cary, NC, USA).
2.5. National Birth Defects Prevention Study
We used the National Birth Defects Prevention Study (NBDPS) as an independent sample to
further evaluate the relationship between atrazine and CHDs. These analyses were approved by the
institutional review boards (IRBs) of each NBDPS site, the Centers for Disease Control and Prevention,
and the University of Texas Health Science Center at Houston.
The NBDPS is a large population-based case-control study of major birth defects in ten U.S.
states. The details of subject selection and data collection methods have been reported previously [34].
Briefly, a detailed computer-assisted telephone interview, which included questions about maternal
exposures before and during pregnancy, was conducted among mothers of infants with and without
birth defects. For the present study, potential cases included babies with any CHD ascertained by
the NBDPS [35], among live births, stillbirths, and elective terminations. All cases had confirmation
by echocardiography, cardiac catheterization, surgery, or autopsy [36]. Cases with chromosome
abnormalities or syndromes were not included in the NBDPS. Controls were live-born infants without
any major birth defect, randomly selected from vital records or hospital discharge information, in the
same areas and in the same study periods from which cases were selected.
NBDPS cases and controls delivered from 1997–2005 were available for analysis. In our main
analyses, only subjects delivered from 1 January 1999 through 31 December 2005 were included,
to match the study period used in the Texas analyses. Our NBDPS analyses were restricted to subjects
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from Arkansas (statewide), Iowa (statewide), North Carolina (northern Piedmont region counties,
deliveries starting in 2003), and Utah (statewide, deliveries starting in 2003) of the NBDPS. Subjects
from several other sites were excluded due to a high proportion of subjects residing in water districts,
for which atrazine data were not available from the EPA. Subjects in the NBDPS from Texas were
excluded to avoid overlap with subjects in the Texas analyses.
Atrazine exposure was assessed based on the linkage of maternal address at conception to the
water supply district and the reported atrazine levels for each district from the EPA. If multiple
addresses were reported during the month before conception through the third month of pregnancy,
we used the first (i.e., earliest) address. The public water supply districts for mothers were identified
by overlaying addresses with digitized service area maps for public water supplies obtained from
local state agencies or municipal water utilities for each state [37]. If use of the digitized maps failed
to identify a subject’s district, the district was assigned based on census place boundaries or, in rare
instances, using interactive searching methods [37].
Using the same methods as in our Texas analyses, we repeated our main analyses using NBDPS
data. Because the NBDPS had some CHD subtypes with small numbers and had relatively lower mean
atrazine levels compared to Texas (90th percentile in controls: 0.41 µg/L in Texas versus 0.08 µg/L in
NBDPS), atrazine values were categorized using different cut-offs for NBDPS to make the distribution
more comparable to Texas categories: “low” (<the 95th percentile) and “high” (≥the 95th percentile).
We adjusted for the same potential confounders as in the Texas analyses, except for rural/urban status,
which was not available in the NBDPS. We also included an additional secondary regression model,
adjusting for two variables that were not available for Texas subjects: household income (<$10,000,
$10,000–50,000, and >$50,000) and supplemental folic acid intake (yes or no). For comparison to the
secondary analyses among Texas subjects, we also repeated any CHD analyses among subjects in
water districts serving a population size >25,000. (Analyses among districts serving >200,000 people
or for specific CHD subtypes among districts serving >25,000 people could not be performed due to
small numbers.) We also repeated analyses for any CHD among subjects in water districts serving
>25,000 people using the median atrazine level (≤50th percentile versus >50th percentile).
3. Results
3.1. Texas Birth Defects Registry
There were 43,512 infants with non-syndromic CHDs in Texas during 1999–2008. We randomly
selected 10,000 controls among live-born infants statewide during this period. Out of 53,512 total
subjects, 5889 (11.0% of cases and 11.1% of controls) did not fall within a public water system boundary
(i.e., those with private wells) and were excluded. We also excluded 11,995 subjects (22.1% cases
and 24.0% controls) who resided in water districts without any recorded atrazine levels during the
monitoring period (1999–2005). Characteristics of these subjects were assessed (see below). Our main
analyses were restricted to deliveries during 1999–2005 (i.e., years with atrazine measurements),
resulting in 22,705 included subjects (18,291 cases and 4414 controls). (An additional 12,923 subjects
delivered during 2006–2008 were included in a sensitivity analyses, described below.)
Frequencies and distributions for demographic and reproductive characteristics of cases and
controls were tabulated (Table 1). There were significant differences between cases and controls in
the distribution of maternal age, race/ethnicity, birthplace, pregestational or gestational diabetes, and
plurality, as well as infant sex and delivery year. Further, there were differences in the distribution of
residential factors between cases and controls, including the population size the water district served
and the region of Texas where the mother resided.
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Table 1. Descriptive characteristics of cases and controls with available atrazine data, Texas, 1999–2005.
Characteristic a
Cases Controls
p-Value b
N % N %
Total 18,291 100.0 4,414 100.0
Delivery year <0.001
1999 2027 11.1 570 12.9
2000 2187 12.0 662 15.0
2001 2362 12.9 643 14.6
2002 2534 13.9 617 14.0
2003 2698 14.8 633 14.3
2004 3052 16.7 640 14.5
2005 3431 18.8 649 14.7
Infant sex 0.002
Male 9476 51.8 2,174 49.3
Female 8814 48.2 2,240 50.8
Plurality of pregnancy <0.001
Yes 1190 6.5 106 2.4
No 17,100 93.5 4,308 97.6
Previous live birth 0.253
Yes 10,836 61.5 2,575 60.6
No 6772 38.5 1,675 39.4
Maternal age <0.001
<20 2516 13.8 674 15.3
20–24 4947 27.1 1,336 30.3
25–29 4643 25.4 1,132 25.7
30–34 3645 19.9 841 19.1
35–39 1982 10.8 350 7.9
≥40 554 3.0 80 1.8
Maternal race/ethnicity <0.001
Non-Hispanic White 5465 29.9 1,349 30.6
Non-Hispanic Black 2104 11.5 567 12.9
Hispanic 10,290 56.3 2,348 53.3
Other 411 2.3 140 3.2
Mother’s education 0.523
Less than high school 6301 35.0 1,498 34.5
High school 5646 31.3 1,342 30.9
Greater than high school 6084 33.7 1,506 34.7
Mother’s birthplace in US <0.001
Yes 12,861 70.7 2,985 67.9
No 5326 29.3 1,413 32.1
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Table 1. Cont.
Characteristic a
Cases Controls
p-Value b
N % N %
Maternal cigarette smoking 0.201
Yes 1052 5.8 231 5.3
No 17,146 94.2 4,142 94.7
Maternal gestational or
pregestational diabetes <0.001
Yes 1190 6.5 136 3.1
No 17,014 93.5 4,278 96.9
Water district population size <0.001
<5000 4695 25.7 1,165 26.4
5000–200,000 4261 23.3 901 20.4
>200,000 9334 51.0 2,348 53.2
Texas Public Health region <0.001
1 901 4.9 186 4.2
2 426 2.3 98 2.2
3 4342 23.7 1,033 23.4
4 329 1.8 140 3.2
5 290 1.6 102 2.3
6 2845 15.6 995 22.5
7 1423 7.8 465 10.5
8 2321 12.7 553 12.5
9 554 3.0 122 2.8
10 585 3.2 229 5.2
11 4275 23.4 491 11.1
Rural/urban status 0.157
Metropolitan, urbanized 16,808 91.9 4,041 91.6
Non-metropolitan, urban 659 3.6 147 3.3
Less urbanized 824 4.5 226 5.1
a Some characteristic counts do not sum to the totals due to missing data; b estimated using chi-square test.
In Texas, 26.1% of all potential controls resided in water districts without atrazine data. There
was a significant association between missing atrazine data and any CHD (p-value < 0.001, data not
shown). To better characterize these subjects, we compared the distributions of demographic and
reproductive characteristics between potential control subjects (all live born infants without birth
defects in Texas between 1999 and 2005) with and without atrazine data (Table 2). There were significant
differences (p-value < 0.001) in the distributions of 11 of these 13 factors. The differences with the largest
magnitudes of effects were maternal race/ethnicity and residential factors, including population size
of the water district served, region in Texas, and urban/rural status. Of note, atrazine measurements
were present for 94.6% of potential control subjects residing in districts serving >200,000 people.
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Table 2. Descriptive characteristics of potential controls with and without atrazine data in
Texas, 1999–2005.
Characteristic a
Atrazine Data Missing Atrazine Data
OR (95%CI) p-Value bN % N %
Total 1,585,927 100.0 561,149 100.0
Delivery year <0.001
1999 215,516 13.6 71,562 12.8 Ref.
2000 222,837 14.1 74,337 13.3 1.01 (0.99–1.02)
2001 222,426 14.0 77,646 13.8 1.05 (1.04–1.06)
2002 228,332 14.4 80,270 14.3 1.06 (1.05–1.07)
2003 227,179 14.3 82,001 14.6 1.09 (1.07–1.10)
2004 233,153 14.7 86,068 15.3 1.11 (1.10–1.13)
2005 236,484 14.9 89,265 15.9 1.14 (1.12–1.15)
Infant sex 0.939
Male 805,690 50.8 285,111 50.8 Ref.
Female 780,237 49.2 276,038 49.2 1.00 (0.99–1.01)
Plurality of pregnancy <0.001
Yes 42,004 2.7 17,657 3.2 1.19 (1.17–1.22)
No 1,543,831 97.4 543,463 96.9 Ref.
Previous live birth <0.001
Yes 934,055 61.1 328,080 60.3 0.97 (0.96–0.98)
No 595,729 38.9 215,725 39.7 Ref.
Maternal age <0.001
<20 241,094 15.2 62,557 11.2 0.70 (0.69–0.71)
20–24 464,051 29.3 136,582 24.3 0.79 (0.79–0.80)
25–29 418,122 26.4 155,022 27.6 Ref.
30–34 303,334 19.1 134,909 24.0 1.20 (1.19–1.21)
35–39 131,809 8.3 60,184 10.7 1.23 (1.22–1.25)
≥40 27,403 1.7 11,837 2.1 1.17 (1.14–1.19)
Race/ethnicity <0.001
Non-Hispanic White 488,010 30.8 287,212 51.3 Ref.
Non-Hispanic Black 195,843 12.4 60,380 10.8 0.52 (0.52–0.53)
Hispanic 849,795 53.7 178,962 32.0 0.36 (0.36–0.36)
Other 49,929 3.2 33,506 6.0 1.14 (1.12–1.16)
Education <0.001
Less than high school 548,329 35.1 130,606 23.7 0.72 (0.71–0.72)
High school 473,853 30.3 158,530 28.7 Ref.
Greater than high school 540,961 34.6 262,870 47.6 1.45 (1.44–1.46)
Mother’s birthplace in US <0.001
Yes 1,079,009 68.0 411,507 73.3 Ref.
No 506,918 32.0 149,642 26.7 0.77 (0.77–0.78)
Cigarette smoking during pregnancy <0.001
Yes 84,209 5.4 36,924 6.6 1.25 (1.24–1.27)
No 1,489,334 94.7 521,828 93.4 Ref.
Maternal gestational or pregestational diabetes 0.939
Yes 46,557 2.9 16,462 2.9 1.00 (0.98–1.02)
No 1,539,369 97.1 544,686 97.1 Ref.
Water district population size <0.001
<5000 417,393 26.3 362,324 64.6 Ref.
5000–200,000 327,863 20.7 150,244 26.8 0.53 (0.52–0.53)
>200,000 840,649 53.0 48,366 8.6 0.07 (0.07–0.07)
Texas Public Health region <0.001
1 66,241 4.2 2,313 0.4 0.05 (0.05–0.05)
2 34,809 2.2 7,143 1.3 0.30 (0.29–0.30)
3 371,655 23.4 258,949 46.2 Ref.
4 45,544 2.9 18,231 3.3 0.58 (0.56–0.59)
5 36,130 2.3 9,074 1.6 0.36 (0.35–0.37)
6 358,067 22.6 171,153 30.5 0.67 (0.68–0.69)
7 174,704 11.0 55,537 9.9 0.46 (0.45–0.46)
8 196,342 12.4 14,649 2.6 0.11 (0.11–0.11)
9 40,897 2.6 1,164 0.2 0.04 (0.04–0.04)
10 82,199 5.2 6,603 1.2 0.12 (0.11–0.12)
11 179,339 11.3 16,333 2.9 0.13 (0.13–0.13)
Urban/rural status <0.001
Metropolitan, urbanized 1,451,694 91.5 520,544 92.8 Ref.
Non-metropolitan, urban 57,631 3.6 12,773 2.3 0.62 (0.61–0.63)
Less urbanized 76,602 4.8 27,832 5.0 1.01 (1.00–1.03)
OR, (crude) odds ratio for missing atrazine; CI, confidence interval; a some characteristic counts do not sum to the
totals due to missing data; b estimated using chi-square test.
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In our main association analyses, we assessed eight specific CHD subtypes as well as any CHD
(Table 3). In these analyses, there was a negative association between high versus low mean atrazine
level and ventricular septal defects (AOR 0.8, 95% CI: 0.6, 1.0), after adjusting for delivery year,
maternal age, race/ethnicity, education, birthplace, smoking, and history of previous live birth, and a
similar result was observed after adjusting for water district population size and rural/urban status.
The atrazine level was not significantly associated with any of the other seven CHD subtypes assessed
or with any CHD in either adjusted model (range of adjusted odds ratios (AOR): 0.8–1.5). We repeated
these analyses during an extended time period, for deliveries during 1999 through 2008, and these
results were similar (data not shown). We repeated the main analysis for any CHD after excluding
region 11 of Texas (where CHD cases may have been potentially over-ascertained) [33] and results
were similar (data not shown).
Table 3. Association between estimated high mean atrazine in drinking water and heart defects in
offspring in Texas, 1999–2005.
Title
Controls Cases
OR (95% CI) AOR a (95% CI) AOR b (95% CI)
N (%) N (%)
Any CHD
Low mean atrazine 3,755 (85.1) 16,009 (87.5) Ref. Ref. Ref.
High mean atrazine c 659 (14.9) 2282 (12.5) 0.83 (0.65–1.06) 0.84 (0.66–1.06) 0.83 (0.65–1.05)
ASD
Low mean atrazine 3,755 (85.1) 4,081 (87.3) Ref. Ref. Ref.
High mean atrazine c 659 (14.9) 593 (12.7) 0.97 (0.69–1.37) 0.95 (0.67–1.36) 0.96 (0.68–1.35)
VSD
Low mean atrazine 3,755 (85.1) 6,271 (87.5) Ref. Ref. Ref.
High mean atrazine c 659 (14.9) 894 (12.5) 0.73 (0.57–0.94) 0.75 (0.58–0.95) 0.73 (0.57–0.94)
AVSD
Low mean atrazine 3,755 (85.1) 103 (88.0) Ref. Ref. Ref.
High mean atrazine c 659 (14.9) 14 (12.0) 0.77 (0.44–1.36) 0.84 (0.47–1.49) 0.80 (0.45–1.41)
CTD
Low mean atrazine 3,755 (85.1) 782 (86.2) Ref. Ref. Ref.
High mean atrazine c 659 (14.9) 125 (13.8) 0.87 (0.66–1.15) 0.91 (0.69–1.20) 0.87 (0.66–1.15)
Tetralogy of Fallot
Low mean atrazine 3,755 (85.1) 359 (85.3) Ref. Ref. Ref.
High mean atrazine c 659 (14.9) 62 (14.7) 0.98 (0.74–1.31) 1.02 (0.75–1.38) 1.00 (0.75–1.32)
LVOT
Low mean atrazine 3,755 (85.1) 133 (81.6) Ref. Ref. Ref.
High mean atrazine c 659 (14.9) 30 (18.4) 1.29 (0.84–1.97) 1.31 (0.86–1.99) 1.29 (0.84–1.97)
RVOT
Low mean atrazine 3,755 (85.1) 416 (79.9) Ref. Ref. Ref.
High mean atrazine c 659 (14.9) 105 (20.2) 1.30 (0.91–1.86) 1.32 (0.91–1.92) 1.31 (0.92–1.86)
Pulmonary valve stenosis
Low mean atrazine 3,755 (85.1) 348 (78.0) Ref. Ref. Ref.
High mean atrazine c 659 (14.9) 98 (22.0) 1.46 (0.98–2.16) 1.47 (0.98–2.21) 1.47 (1.00–2.16)
CHD, congenital heart defect; OR, (crude) odds ratio (odds of cases between the exposed group to high mean atrazine
and the unexposed group); AOR, adjusted odds ratio; ASD, atrial septal defect; VSD, ventricular septal defect,
AVSD, atrioventricular septal defect; CTD, conotruncal heart defect; LVOT, left ventricular outflow tract; RVOT,
right ventricular outflow tract; a adjusted for delivery year, maternal age, race/ethnicity, education, birthplace,
smoking, and history of previous live birth; b adjusted for population size of water district and rural/urban status; c
“high mean atrazine” defined as ≥85th percentile (0.16 µg/L) of mean values across all atrazine measurements in
controls, 1999–2005; otherwise, “low mean atrazine”.
To address the possibility of selection bias related to subjects in districts missing atrazine
measurements, we also repeated the main analyses for any CHDs, restricting to subjects in water
districts serving >200,000 people, as few subjects in these districts were missing atrazine exposure
estimates. In these analyses (Table 4), high versus low median and mean atrazine levels were not
significantly associated with any CHD. We also repeated the analyses shown in Tables 3 and 4 after
using the value for the minimal detectable limit (MDL) instead of 0 when a measurement was at or less
than the MDL (97.3% of subjects did not change exposure category), and results from these analyses
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were similar to the main results (data not shown). We also repeated the main analyses for any CHDs
using a three-level exposure variable (i.e., low, high, and missing), and the results for high versus low
atrazine were similar to the main results (data not shown).
Table 4. Association between estimated atrazine exposure in drinking water and congenital heart
defects in offspring in Texas, 1999–2005, among districts with population size >200,000.
Any CHD
Controls Cases
OR (95% CI) AOR a (95% CI)
N (%) N (%)
High median atrazine
No (<95th percentile b) 1,904 (81.1) 7,766 (83.2) Ref. Ref.
Yes (≥95th percentile b) 444 (18.9) 1,568 (16.8) 0.82 (0.34–1.99) 0.79 (0.32–1.91)
High mean atrazine
No (<95th percentile b) 1,904 (81.1) 7,766 (83.2) Ref. Ref.
Yes (≥95th percentile b) 444 (18.9) 1,568 (16.8) 0.82 (0.34–1.99) 0.79 (0.32–1.91)
CHD, congenital heart defect; OR, (crude) odds ratio; AOR, adjusted odds ratio; a adjusted for delivery year,
maternal age, race/ethnicity, education, birthplace, smoking, and history of previous live birth; b all percentiles
were based on data from full controls, 1999–2005 (0.37 µg/L for 95th percentile median, 0.41 µg/L for 95th
percentile mean).
3.2. National Birth Defects Prevention Study
For comparison, we conducted similar analyses in the NBDPS for deliveries during 1999 through
2005. A total of 3591 subjects were available in the NBDPS and 636 subjects (8.7% of cases, 19.4% of
controls) were excluded due to missing atrazine values, resulting in 2955 included subjects (1620 cases
and 1335 controls). Demographic and reproductive characteristics were compared (Table S1), and
differences were observed for state, delivery year, plurality, maternal age, maternal pregestational or
gestational diabetes, and water district population size between cases and controls. In the NBDPS,
19.4% of control mothers were missing atrazine information, and differences in the distributions of
state, delivery year, maternal age, household income, maternal pregestational or gestational diabetes,
and water district population size were present between control subjects in districts with versus
without atrazine measurements (Table S2). However, the distribution of missing atrazine data was not
different between cases with any CHD and controls (p-value = 0.126)
We repeated our main association analyses in the NBDPS (Table 5). In these analyses, there
was a negative association between high versus low mean atrazine level and left ventricular outflow
tract defects (AOR 0.4, 95% CI: 0.2, 0.9) after adjusting for delivery year, maternal age, race/ethnicity,
education, birthplace, smoking, and history of previous live birth. The magnitude of this result was
similar after adjusting for water district population size, and after adjusting for potential confounding
factors not present in the Texas data (i.e., household income and folic acid intake). The atrazine level
was not significantly associated with any of the other six CHD subtypes assessed or with any CHD in
either adjusted model (range of adjusted odds ratios (AOR): 0.5–1.2).
When limiting any CHD analyses to water districts serving >25,000 people to minimize potential
selection bias in the NBDPS (11.2% of cases and 12.5% of control subjects missing atrazine), the results
were similar to those from the main analysis in Table 5 (data not shown). When using the median
atrazine level in these analyses, the results were also similar to those from Texas (data not shown).
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Table 5. Association between estimated high mean atrazine in drinking water and heart defects
delivered in NBDPS a, 1999–2005.
Controls Cases
OR (95% CI) AOR b (95% CI) AOR c (95% CI) AOR d (95% CI)
N (%) N (%)
Any CHD
Low mean atrazine 1,249 (93.6) 1,542 (95.2) Ref. Ref. Ref. Ref.
High mean atrazine e 86 (6.4) 78 (4.8) 0.64 (0.37–1.12) 0.60 (0.34–1.05) 0.65 (0.37–1.13) 0.64 (0.36–1.11)
ASD
Low mean atrazine 1,249 (93.6) 364 (96.8) Ref. Ref. Ref. Ref.
High mean atrazine e 86 (6.4) 12 (3.2) 0.50 (0.22–1.17) 0.47 (0.20–1.11) 0.52 (0.22–1.19) 0.53 (0.22–1.25)
VSD
Low mean atrazine 1,249 (93.6) 247 (94.6) Ref. Ref. Ref. Ref.
High mean atrazine e 86 (6.4) 14 (5.4) 0.56 (0.23–1.38) 0.55 (0.22–1.36) 0.58 (0.24–1.41) 0.46 (0.18–1.18)
CTD
Low mean atrazine 1,249 (93.6) 226 (93.4) Ref. Ref. Ref. Ref.
High mean atrazine e 86 (6.4) 16 (6.6) 0.89 (0.37–2.13) 0.79 (0.33–1.88) 0.99 (0.44–2.27) 0.95 (0.41–2.19)
Tetralogy of Fallot
Low mean atrazine 1,249 (93.6) 102 (93.6) Ref. Ref. Ref. Ref.
High mean atrazine e 86 (6.4) 7 (6.4) 0.89 (0.25–3.14) 0.85 (0.26–2.80) 1.15 (0.39–3.39) 0.90 (0.26–3.04)
LVOT
Low mean atrazine 1,249 (93.6) 266 (97.1) Ref. Ref. Ref. Ref.
High mean atrazine e 86 (6.4) 8 (2.9) 0.40 (0.16–1.04) 0.36 (0.15–0.91) 0.41 (0.16–1.07) 0.38 (0.15–0.98)
RVOT
Low mean atrazine 1,249 (93.6) 250 (94.3) Ref. Ref. Ref. Ref.
High mean atrazine e 86 (6.4) 15 (5.7) 0.69 (0.29–1.63) 0.67 (0.29–1.55) 0.74 (0.32–1.71) 0.70 (0.30–1.63)
Pulmonary valve stenosis
Low mean atrazine 1,249 (93.6) 253 (94.8) Ref. Ref. Ref. Ref.
High mean atrazine e 86 (6.4) 14 (5.2) 0.62 (0.25–1.51) 0.60 (0.25–1.45) 0.64 (0.26–1.53) 0.63 (0.26–1.54)
NBDPS, National Birth Defects Prevention Study; CHD, congenital heart defect; OR, (crude) odds ratio (odds of cases
between the exposed group to high mean atrazine and the unexposed group); AOR, adjusted odds ratio; ASD, atrial
septal defect; VSD, ventricular septal defect, AVSD, atrioventricular septal defect; CTD, conotruncal heart defect;
LVOT, left ventricular outflow tract; RVOT, right ventricular outflow tract; a NBDPS included data from Arkansas,
Iowa, North Carolina, and Utah; b adjusted for delivery year, maternal age, race/ethnicity, education, birthplace,
smoking, and history of previous live birth; c adjusted for only population size of water district; d adjusted for only
household income and folic acid intake; e “high mean atrazine” defined by as ≥95th percentile (0.14 µg/L) of mean
values across all atrazine measurements in controls, 1999–2005; otherwise, “low mean atrazine”.
4. Discussion
We examined the association between maternal exposure to atrazine in public drinking water and
CHDs in offspring using two large data sources. In our main analyses for Texas (1999–2005), estimated
high atrazine exposure in public drinking water was not positively associated with any of the eight
CHD subtypes assessed or any CHD (i.e., the group of any CHDs). In fact, ventricular septal defects
were negatively associated with atrazine in Texas. In follow-up analyses in the NBDPS (1999–2005),
no positive associations were observed between atrazine and any of the seven CHD subtypes assessed
or any CHD, and a negative association was observed with left ventricular outflow tract defects. The
observed magnitude of effect was <1 for most comparisons within the NBDPS. Our findings were
similar across several sensitivity analyses, and do not support a positive association between atrazine
and CHDs. However, our findings should be interpreted in light of limitations of the data.
Similar to other studies that have used water-district level data for exposure estimates [24,38], the
accuracy of our exposure estimates is uncertain. Given the relative rarity of birth defects, prospective
studies with direct individual-level measurements are not feasible and exposure estimates may be
the only available data. In the data we analyzed, there were a large proportion of water districts
missing atrazine data, especially in Texas. As mothers in Texas districts with atrazine data had
different distributions of several characteristics compared to those without atrazine data, it is possible
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that our analyses were impacted by selection bias, and that our results may not generalize to all
women. However, when we accounted for subjects with missing data using a 3-level exposure variable
(low/high/missing), the estimate for low versus high exposure did not change, which may suggest
that there were not major effects due to missing exposure data.
We tried to further limit this potential selection bias by conducting sensitivity analyses among
subjects in districts with more complete atrazine measurements (i.e., districts serving large populations),
though these analyses could not be conducted for specific CHD subtypes due to small case numbers.
We further tried to limit potential selection bias by using a secondary data source with more complete
exposure data (i.e., the NBDPS), though substantially fewer cases were present among this data source.
These limitations with the exposure data highlight the lack of complete collection and curation of
public data on at least some pesticide water contaminants. It was unclear from these analyses if the
atrazine data were missing because of districts not complying with mandatory reporting requirements,
not properly reporting the data to the EPA, or another issue. Further, as several published studies have
used water district monitoring data for similar analyses (e.g., other contaminants or outcomes), our
findings emphasize the need for caution in interpreting results from such studies, which do not always
address the impact of missing exposure data.
We observed negative associations between high versus low atrazine and two CHD subtypes:
ventricular septal defects (VSDs) and left ventricular outflow tract (LVOT) defects. As we are not
aware of any hypothesized protective effect of atrazine on birth defects (and these results were not
entirely consistent between Texas and the NBDPS), we suspect that these observations may have arisen
due to the limitations of the data (e.g., selection bias and/or measurement error). Alternatively, we
cannot rule out the possibility that these trends might be explained by a relationship between atrazine
and a very severe phenotype that resulted in an early fetal death or miscarriage (i.e., potential cases
that were not ascertained). In fact, early fetal death/miscarriage has been associated with atrazine in
animal [39] and human [40,41] studies.
Some previous studies have reported on the reproductive effects of atrazine. In animal studies,
atrazine exposure has been associated with developmental effects, though relatively few of these
studies have focused on malformations of the heart. Both zebrafish and rats have shown functional
disturbances of the heart following atrazine exposure [42–44]. Another study observed that 23% of
chicken embryos treated with N-nitrosoatrazine (which is formed when atrazine reacts with nitrite)
had malformations, including CHDs [45].
Few studies have examined risks of CHDs in humans and pesticide exposure from water. Based
on ecologic data, it was observed that Iowa communities served by a water reservoir contaminated
with atrazine had higher rates of CHDs compared to other communities [46], but individual-level data
were not available. Although a U.S. ecological study reported a correlation between surface water
atrazine and birth defects overall [24], to our knowledge no prior analytic study has evaluated atrazine
in water and individual-level risk of CHDs specifically.
However, other previous observational studies have reported links between atrazine in drinking
water and non-CHD birth defects or reproductive outcomes. For example, a study from the NBDPS
reported a weak association between atrazine (estimated based on catchment level stream and
groundwater contaminant models) in drinking water and hypospadias [47]. In addition, a U.S. study
observed an elevated prevalence of abdominal wall defects during months when seasonal patterns
of atrazine and nitrate levels in surface water peaked [22], and in a semi-ecological study, the risk of
gastroschisis was inversely associated with distance to the site of elevated atrazine exposure in surface
water [23]. Some studies found that atrazine in drinking water was significantly associated with small
for gestational age or preterm birth [30,48,49], whereas others did not find associations [50].
Although suspected effects of atrazine may be related to the combinations of multiple pesticides,
agricultural compounds, or other chemicals in drinking water [21], few studies have assessed the effects
of any of these water contaminants and CHDs. Chlorination byproducts, arsenic, and manganese in
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water have been independently associated with CHDs [51–53], and inconsistent results have been
reported for nitrate in water and CHD risk [37,51,54].
In addition to water, occupational exposure is another important potential pesticide exposure
source. Multiple studies have assessed occupational exposure to pesticides and CHDs, but the
relationship is unclear. Briefly, Rocheleau et al. assessed maternal occupational exposure to pesticides
and CHDs in the NBDPS [10] and found that maternal occupations with exposure to herbicides
were associated with hypoplastic left heart syndrome, pulmonary valve stenosis, and tetralogy of
Fallot. An additional case-control study conducted in Maryland found that mothers of cases with
transposition of great arteries in offspring were more likely to use pesticides (at home, work, or other
site) before or during pregnancy than mothers of controls [13]. However, a case-control study in China
observed that maternal occupational exposure to pesticides during the periconceptional period was
not associated with simple isolated CHDs [55], and another case-control study from California in U.S.
also reported no association, but it had very few exposed cases (n = 7) [56].
Several studies have also assessed residential proximity to sites with agricultural pesticide
application exposure and CHDs, although results have also been inconsistent. A population-based,
case-control study observed that mothers residing near an area with agricultural pesticide application
were more likely to have specific CHD subtypes in offspring than mothers who did not [11]. Another
case-control study in North Carolina found that mothers exposed to high levels of agricultural
pesticides near their residence had elevated risk of CHDs compared to mothers exposed to low
levels of those pesticides [12]. Conversely, a registry-based, case-control study from Washington State
revealed that neither higher proportions of agricultural land in the mother’s residence county nor
agriculture-related maternal occupation were associated with the risk of ventricular septal defects [57].
Strengths of the present study include the use of population-based data, the large numbers of
study subjects, the data on many potential covariates, the restriction to nonsydromic cases, the case
classification review by clinicians (all NBDPS cases and a subset of Texas cases), and the repetition
of similar analyses across independent data sources. However, there are limitations that need to be
considered in the interpretation of our findings. Due to relatively sparse data on exposure levels over
time for many districts (e.g., 26.1% of Texas control women’s districts were missing atrazine levels),
we could not restrict the exposure time period to the critical period for heart development during early
pregnancy. Instead, we used representative values of atrazine levels for each water district (e.g., mean)
over the entire six-year monitoring period to define high or low atrazine groups, which may not have
reflected atrazine levels during pregnancy (e.g., annual/seasonal changes were not reflected). Such a
lack of seasonal specificity in atrazine levels might have led to measurement errors in this study, which
may have biased effects towards the null. Also, the maternal residential address at conception was
available in the NBDPS data, but not in the Texas data. As such, we used the address at delivery as a
proxy in the Texas data. Results from previous studies assessing residential mobility during pregnancy
in Texas and elsewhere suggest that this was unlikely to have made a major impact [58,59]. However,
since we cannot ignore a possibility of measurement error due to the use of proxy addresses, formal
measurement error modeling (e.g., Berkson model) would be of interest in future work.
As individual-level exposure data were not available, maternal atrazine exposure was estimated
using ecologic-level data (water districts), and, similarly to other studies that have used water district
data, we cannot rule out that an effect related to the ecological fallacy influenced our findings.
To address this, we used mixed-effects models to take into account the latent correlation of atrazine
levels between subjects within the same district. However, we cannot rule out the possibility of
exposure misclassification related to atrazine measurement differences within or between water
systems (e.g., season or frequency), which might have resulted in bias. Our main analyses also did not
account for variability in water use and consumption habits (e.g., not consuming tap water at home),
although there are future planned analyses to address these habits in the NBDPS. Further, it is not
clear if the relatively low ranges of atrazine levels measured in this study were sufficiently large to
potentially produce a detectable effect.
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Although we used two of the largest sources of birth defects data worldwide, small numbers
among specific CHD subtypes did not allow for some of our sensitivity analyses to be conducted
among these subgroups. Instead, we conducted these analyses among cases with any CHD, though
these secondary analyses may have been limited by etiologic heterogeneity.
5. Conclusions
Our study examined the association between estimated maternal atrazine exposure in drinking
water and the risk of CHD subtypes in offspring. No positive associations were observed between
atrazine and CHDs, though our findings should be interpreted in light of the limitations of our study.
More consistent monitoring, reporting, and curation of pesticide water contaminants in public water
sources might aid in further characterizing potential associations. Considering the current limitations
of water district data and with the absence of relevant biomarkers of exposure, our findings suggest
that use of other data sources as proxies for water contaminant exposure (e.g., proximity to pesticide
application sites) may be helpful. If environmental contaminant measurements from maternal/infant
blood samples become available in future studies, this would also be beneficial.
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